Conditions of Use of Cre-Luc GPCR Mouse Model (‘Model”)
Luciferase Animals Conditions of Use
- The Model will be used for research purposes only.
- The Model will not be bred except to obtain embryos or fetuses required for research purposes (e.g., for obtaining embryonic neurons).
- Purchasers may not (i) cross-breed the Model, (ii) genetically alter the Model or Biological Materials, and (iii) establish or maintain a culture of any Biological Materials (e.g., cell lines containing luciferase), with the exception of primary cells (e.g., neurons).
- The Model and Biological Materials derived from it will not be distributed to third parties or used for commercial purposes.
- Purchasers may not use this Model and/or Biological Materials derived from it in commercially sponsored research or contract research or contract research studies unless a separate Limited Use Agreement is signed.
Promega Corporation provides the following limited use license with respect to the luciferase gene (the "product") contained within the Cre-Luc Models. BY USE OF THE PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT. If the researcher is not willing to accept the conditions of this limited use statement, and the product is unused, Taconic will accept written certification that the product was destroyed prior to use and will provide the researcher with a full refund. Researchers may use this product for research use only, no commercial use is allowed. Commercial Use means any and all uses of this product and derivatives by a party for monetary or other consideration and may include but is not limited to use in: (1) product manufacture; and (2) to provide a service, information or data; and/or resale of the product or its derivatives, whether or not such product or derivatives are resold for use in research. Researchers shall have no right to modify or otherwise create variations of the nucleotide sequence of the luciferase gene except that Researchers may: (1) create fused gene sequences provided that the coding sequence of the resulting luciferase gene has no more than four deoxynucleotides missing at the affected terminus compared to the intact luciferase gene sequence, and (2) insert and remove nucleic acid sequences in splicing research predicated on the inactivation or reconstitution of the luminescence of the encoded luciferase. No other use or transfer of this product or derivatives is authorized without the prior express written consent of Promega. In addition, Researchers must either: (1) use luminescent assay reagents purchased from Promega Corporation for all determinations of luminescence activity of this product and its derivatives; or (2) contact Promega Corporation to obtain a license for use of the product and its derivatives. Researchers may transfer derivatives to others for research use provided that at the time of transfer a copy of this label license is given to the recipients and recipients agree to be bound by the terms of this label license. With respect to any uses outside this label license, including any diagnostic, therapeutic or prophylactic uses, please contact Promega Corporation for supply and licensing information. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THE PRODUCT. The terms of this license shall be governed under the laws of the State of Wisconsin, USA. The above license relates to Promega patents and/or patent applications on improvements to the luciferase gene.